Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (648)
    • Blood Glucose Meters (3)
    • Complications (177)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (68)
    • Drug-Induced Hypo/Hyperglycemia (133)
    • Monitoring (121)
    • Natural Medicines/Supplements (13)
    • Prevention (56)
    • Treatment (323)
      • Alpha-Glucosidase Inhibitors (28)
      • Amylin Agonist (14)
      • Bromocriptine (7)
      • Combination Products (18)
      • Gliptins (77)
      • Glitazones (115)
      • GLP-1 (39)
      • Incretin Enhancers/Mimetics (64)
      • Insulin (164)
      • Meglitinides (41)
      • Metformin (151)
      • SGLT2 Inhibitors (80)
      • Sulfonylureas (108)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (12)
  • Hyperglycemia (27)
  • Hypoglycemia (28)
  • Other (26)
  • Prediabetes (5)
  • Resources (221)
  • Thyroid Disorders (49)
91 - 105 of 323 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Consider High-Concentration Entuzity for Insulin-Resistant Patients December 2017
Commentary: Calculating Renal Function in Adults December 2017
Article: Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes November 2017
Chart: Contrast-Associated Acute Kidney Injury November 2017
Article: Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease September 2017
PL Voices: Management of Nonalcoholic Fatty Liver Disease September 2017
Commentary: Overview of Nonalcoholic Fatty Liver Disease September 2017
Chart: Insulin Analogs vs Human Insulin September 2017
Article: Consider Whether Flozin Benefits Outweigh Risks August 2017
Article: Watch for Amputation Concerns With Diabetes Med Invokana July 2017
Algorithm: Stepwise Treatment of Hypertension (Canada)

June 2017
Article: Think of Fiasp as a Faster-Acting Form of NovoRapid May 2017
Article: Glyxambi Is the First SGLT2/DPP-4 Inhibitor Oral Combo for Type 2 Diabetes April 2017
Article: Explain How Different Insulins Compare March 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved